Lacosamide
CAS: 175481-36-4
Rif. 3D-FL180382
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- (2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide
- (2R)-2-Acetamido-N-benzyl-3-methoxypropanamide
- (2R)-2-acetamido-N-benzyl-3-methoxy-propanamide
- (R)-2-Acetamido-N-benzyl-3-methoxypropionamide
- (R)-2-acetamido-N-benzyl-3-methoxypropanamide
- Add 243037
- Erlosamide
- Harkoseride
- Lacosamide UCB
- Lacoset
- Vedi altri sinonimi
- Lacoset 50
- N~2~-acetyl-N-benzyl-O-methyl-D-serinamide
- Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-
- Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (R)-
- Spm 927
- Vimpat
Lacosamide is a drug that is used for the treatment of epilepsy. It has been shown to inhibit neuronal death in vitro and in animal models, and has been extensively studied for its potential benefits in the treatment of bowel disease. The mechanism of action for lacosamide involves inhibition of the transport of neurotransmitters from the synaptic cleft by binding to the neuronal sodium channels and increasing their recovery rate. Lacosamide has also been found to affect energy metabolism by inhibiting the activity of mitochondrial enzymes such as matrix effect and complex I/III.